Evonik to retain specialty monomers division after methacrylates divestment
Katherine Sale
25-Sep-2018
LONDON (ICIS)–Evonik has decided to retain its specialty monomers division following the anticipated divestment of its methyl methacrylate (MMA) and polymethyl methacrylate (PMMA) business units, according to a letter to customers seen by ICIS on Tuesday.
The company announced in March this year that it is considering spinning off the divisions, with any potential sale potentially fetching a price tag of €1.8bn, according to market analysts.
The specialty monomers division had been expected to be part of the carve-out.
“Evonik’s experience has shown that its specialty methacrylates and its oil additives businesses complement each other,” said the producer.
“The group [with branded name] Visiomer specialty monomers from the Application Monomers product line will be integrated into the Evonik Resource Efficiency segment.”
Evonik’s delivery obligations remain in place, it told its customers.
Pictured: Evonik’s MMA plant in
Shanghai
Source: Evonik
Global News + ICIS Chemical Business (ICB)
See the full picture, with unlimited access to ICIS chemicals news across all markets and regions, plus ICB, the industry-leading magazine for the chemicals industry.
Contact us
Partnering with ICIS unlocks a vision of a future you can trust and achieve. We leverage our unrivalled network of industry experts to deliver a comprehensive market view based on independent and reliable data, insight and analytics.
Contact us to learn how we can support you as you transact today and plan for tomorrow.